All sponsors

Beijing Tide Pharmaceutical Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-31
RECRUITING4
READOUTS ≤12 MONTHS0
Open Beijing Tide Pharmaceutical Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
TCC1727 tablet(1)
NCT05970016
P1/2RecruitingPatients with Advanced Solid Tumors562025-07-30
TRD205 tablets
NCT07121101
P2Not yet recruitingPostoperative Analgesia After Unilateral Hip Arthroplasty402025-11-20
TDI01 suspension
NCT06169722
P1/2Active, not recruitingGVHD, Chronic602026-02 (+13 mo)
TRD205
NCT07123402
P2Enrolling by invitationChronic Postoperative Neuralgia1842026-04-20
TRD205
NCT07543796
P2RecruitingPostoperative Analgesia After Unilateral Hip Arthroplasty2002026-06-27
TCC1727 tablet 90mg
NCT07371663
P1/2RecruitingSolid Cancers; NSCLC (Advanced Non-small Cell Lung Cancer)2662028-09-30
TDI01
NCT07464912
P3RecruitingIdiopathic Pulmonary Fibrosis (IPF)5082029-07-30